The U.S. Food & Drug Administration (FDA) has categorized Cepheid's Xpert MTB/RIF test as 'moderate complexity' under the Clinical Laboratory Improvement Amendments (CLIA). Xpert MTB/RIF test is designed for the rapid molecular detection ...
Tags: moderate Complexity, Medicine